US4871785A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Clouding-resistant contact lens compositions
Assignee: Individual
•
Filing: 1988-02-16
•
Granted: 1989-10-03
•
Expires: 2008-02-16
Abstract
Abstract Contact lens compositions containing monomers or cross-linking materials which result in satisfactory moisture content but lowered protein absorption capability are described. Lenses are comfortable for extended wear, but because of lowered protein absorption do not become opaque, and present less infection risk. Included are compositions with over 20% conventional cross-linkers, with 20-100% cross-linkers which are unsaturated diesters of the alcohol of the formula HO(CH 2 CH 2 O) n H wherein n is 5-300; or 1-69% copolymerizing monomer which is an ester of an alcohol of similar formula; or 0.1-90% cross-linkers which are diesters of the diol of the formula HOCH 2 (CF 2 ) m CH 2 OH, or which contain silyl components such as HO(SiR 2 O) x --; or with inclusions of 1-40% polyethylene glycol or polyethylene oxide; or copolymers containing 1-90% polyethylene oxide segments when the composition does not include carboxylic acids and is not treated with alkali.
Inventors
- 👤 Michael Froix
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 22:51
CPC Classifications
G; G02; G02B; G02B1/00; G02B1/04; G02B1/041; G02B1/043; A; A61; A61L; A61L17/00; A61L17/04; A61L27/00; A61L27/14; A61L27/16
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
47 words
A protein-resistant medical device constructed of a composition comprising a copolymer which includes 1-69% of at least one unsaturated monoester of a polyethylene glycol of the formula HO(CH 2 CH 2 O) n R, wherein n is 8-300 and wherein R is H or lower alkyl (1-4C).
Claim 2
Dependent Claim
47 words
A protein-resistant medical device constructed of a composition comprising a copolymer which includes 1-69% of at least one unsaturated monoester of a polyethylene glycol of the formula HO(CH 2 CH 2 O) n R, wherein n is 8-300 and wherein R is H or lower alkyl (1-4C).
Claim 3
Dependent Claim
48 words
The medical device of claim 1, wherein up to 90% of the unsaturated monoester of said polyethylene glycol is replaced by an unsaturated monoester of an alcohol of the formula HO(CH 2 ) l (CF 2 ) m CF 3 wherein 1 is 1-5 and m is 1-10.
Claim 4
Dependent Claim
66 words
A protein-resistant medical device constructed of a composition comprising a copolymer which includes 1-90% of at least one unsaturated monoester of a polyethylene glycol of the formula HO(CH 2 CH 2 O) n R, wherein n is 8-300, and wherein R is H, lower alkyl or saturated acyl, wherein said composition can absorb more than 40% water content and said composition is not treated with alkali.
Claim 5
Dependent Claim
66 words
A protein-resistant medical device constructed of a composition comprising a copolymer which includes 1-90% of at least one unsaturated monoester of a polyethylene glycol of the formula HO(CH 2 CH 2 O) n R, wherein n is 8-300, and wherein R is H, lower alkyl or saturated acyl, wherein said composition can absorb more than 40% water content and said composition is not treated with alkali.
Claim 6
Dependent Claim
57 words
A protein-resistant medical device constructed of a composition comprising a copolymer which includes 1-90% of at least one unsaturated monoester of a polyethylene glycol of the formula HO(CH 2 CH 2 O) n R, wherein n is 8-300, and wherein R is H, lower alkyl or saturated acyl, wherein said composition does not contain free carboxylic acid.
Claim 7
Dependent Claim
57 words
A protein-resistant medical device constructed of a composition comprising a copolymer which includes 1-90% of at least one unsaturated monoester of a polyethylene glycol of the formula HO(CH 2 CH 2 O) n R, wherein n is 8-300, and wherein R is H, lower alkyl or saturated acyl, wherein said composition does not contain free carboxylic acid.
Claim 8
Dependent Claim
39 words
The medical device of claims 3-6 wherein the polymer of copolymer is formed from one or more monomers selected from the group consisting of unsaturated carboxylic acids and their hydrocarbyl, hydroxylated hydrocarbl, silylated, and fluorinated ester and vinyl derivatives.
Claim 9
Dependent Claim
38 words
The medical device of claim 7 wherein the unsaturated carboxylic acids and esters are selected for HEA, HEMA, MAA, AC, FA, FMA, DHPM, MMA, GMA, AA, HFBMA, IBMA, PDFORMA, TDFOMA, and TRIS, and the vinyl derivative is VP.
Claim 10
Dependent Claim
11 words
The medical device of claims 3-6 which is a contact lens.
Claim 11
Dependent Claim
140 words
A protein-resistant medical device constructed of a composition consisting essentially of a polymer or copolymer cross-linked with a relative percent of 0.1-90% of the unsaturated diester form of at least one diol selected from the group consisting of: (a) at least one polydimethyl siloxane/polyethlene glycol copolymer (PMS/PEG) of the formula HO(Si(Me 2 O)) x --(CH 2 CH 2 O) y H wherein x is 1-300 and y is 1-400; (b) a mixture of said PMS/PEG with at least one fluoromethylene diol (FMD) of the formula HO(CH 2 (CF 2 ) m CH 2 OH wherein m is 1-10; (c) a mixture of said PMS/PEG with at least one polyethylene glycol (PEG) of the formula HO(CH 2 CH 2 O) n H wherein n is 1-300; and (d) a mixture of said PMS/PEG with a mixture of said FMD and PEG.
Claim 12
Dependent Claim
140 words
A protein-resistant medical device constructed of a composition consisting essentially of a polymer or copolymer cross-linked with a relative percent of 0.1-90% of the unsaturated diester form of at least one diol selected from the group consisting of: (a) at least one polydimethyl siloxane/polyethlene glycol copolymer (PMS/PEG) of the formula HO(Si(Me 2 O)) x --(CH 2 CH 2 O) y H wherein x is 1-300 and y is 1-400; (b) a mixture of said PMS/PEG with at least one fluoromethylene diol (FMD) of the formula HO(CH 2 (CF 2 ) m CH 2 OH wherein m is 1-10; (c) a mixture of said PMS/PEG with at least one polyethylene glycol (PEG) of the formula HO(CH 2 CH 2 O) n H wherein n is 1-300; and (d) a mixture of said PMS/PEG with a mixture of said FMD and PEG.
References Cited (Backward Citations)
US4038264A
Cited
US3988274A
Cited
US4170582A
Cited
US4200563A
Cited
US4228269A
Cited
US4327202A
Cited
US4379864A
Cited
US4351922A
Cited
US4275183A
Cited
US4259467A
Cited
US4405773A
Cited
US4433125A
Cited
JPS59181301A
Cited
US4546123A
Cited
US4598122A
Cited
GB2178435A
Cited
US4752627A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-10-02 | 1993-04-03 | 1993-10-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-10-02 | 1997-04-03 | 1997-10-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-10-02 | 2001-04-03 | 2001-10-03 | $7700.00 | Window Closed / Lapsed |